Eicosapentaenoic Acid
Eicosapentaenoic Acid Market by Source (Algae, Fish, Krill), Form (Ethyl Esters, Triglycerides), Application - Global Forecast 2024-2030
360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the eicosapentaenoic acid market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[199 Pages Report] The Eicosapentaenoic Acid Market size was estimated at USD 862.50 million in 2023 and expected to reach USD 904.94 million in 2024, at a CAGR 5.16% to reach USD 1,227.44 million by 2030.

Eicosapentaenoic acid (EPA) is a long-chain omega-3 fatty acid primarily found in oily fish, fish oil supplements, and certain algae. The market for EPA encompasses its production, purification, and applications across various industries. The terrain of the EPA market includes pharmaceuticals, dietary supplements, food & beverages, and animal nutrition, highlighting its diversification in usage and end-consumer benefits. The scope of the EPA market is expanding, with innovation driving into new applications, including biofuels and bioplastics, indicating a broad horizon for growth and development. Growing consumer awareness regarding health and wellness, alongside the desire for natural dietary supplements, significantly drives the demand for EPA. Continuous research substantiating EPA’s efficacy in treating and managing various health conditions bolsters its adoption in pharmaceuticals. Favorable regulations encouraging the use of omega-3s in food and dietary supplements positively affect market growth. Growing attention to sustainable sources of EPA, including microalgae, presents a significant opportunity for eco-conscious market adaptation. Additionally, rising pet healthcare expenditures are also expected to boost the scope for eicosapentaenoic acid within animal nutrition segments.

Regional Insights

The Americas represent a significant market for eicosapentaenoic acid (EPA) owing to the high awareness of omega-3 benefits among consumers and well-established healthcare sectors. The region shows a robust demand for EPA in dietary supplements due to the growing emphasis on preventive healthcare and an aging population prone to cardiovascular diseases. The U.S. holds a significant position in the pharmaceutical sector, where EPA is extensively utilized in formulations aimed at treating conditions including hypertriglyceridemia. The regulatory support from agencies including the FDA for omega-3-based therapeutic products further scaffolds the market growth in this region. The presence of major market players, coupled with aggressive marketing strategies and consumer education on the benefits of omega-3 fatty acids, bolsters the market expansion. The Asia-Pacific region is experiencing rapid growth in the eicosapentaenoic acid market, driven by rising health consciousness and disposable incomes, especially in countries including China, Japan, and India. Japan, being one of the largest consumers of EPA, holds a significant market share due to its traditional diet rich in fish. The region is witnessing a surge in the demand for dietary supplements as consumers are increasingly inclined towards preventive healthcare measures. Additionally, the expansion of the pharmaceutical sector in APAC countries, aimed at developing advanced treatment options for cardiovascular and neurodegenerative diseases, further propels the demand for EPA. Innovation in product development, coupled with an increase in the aquaculture industry, specifically focusing on EPA-rich fish farming, is set to boost the market's growth potential in this region. The EMEA region exhibits a growing interest in Eicosapentaenoic Acid, with Europe leading the charge. The increasing awareness about the benefits of omega-3 fatty acids, coupled with a rising elderly population susceptible to chronic diseases, fuels the demand for EPA-enriched dietary supplements. European countries, with their stringent regulatory frameworks for nutritional products, present a promising market for high-quality, EPA-based pharmaceuticals. The Middle East and Africa are emerging markets with vast growth potential, attributed to a gradual shift towards health and wellness trends and improving healthcare infrastructure. While Europe's mature market focuses on innovation and stringent quality standards, the Middle East and Africa offer untapped opportunities driven by economic diversification and an increasing focus on preventive healthcare.

Eicosapentaenoic Acid Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Eicosapentaenoic Acid Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Significance of EPA for lowering risk of rising prevalence of chronic diseases
    • Rise in spending on nutritional and infant food products
  • Market Restraints
    • Issues associated with availability of raw materials required for EPA
  • Market Opportunities
    • Introduction of sustainable and vegan EPA
    • Rising investments to expand EPA offerings
  • Market Challenges
    • Possibilities of side effects associated with consumption of EPA
Market Segmentation Analysis
  • Source: Growing usage of algal oil that provides a sustainable alternative and meets the ongoing trend of plant-based diets

    Algal oil is a prominent vegetarian source of eicosapentaenoic acid (EPA), derived from microalgae. Such algae are the primary producers of EPA in the marine ecosystem, subsequently consumed and accumulated by fish. Algal oil is especially significant for those following plant-based diets or with fish allergies, providing a sustainable alternative to fish-derived EPA without the heavy metals or pollutants often found in marine environments. Fish, particularly oily fish such as salmon, mackerel, and sardines, are among the most well-known sources of EPA. These species accumulate EPA by consuming algae or other fish that have ingested algae. Fish-derived EPA is widely recognized for its cardiovascular benefits. However, concerns over mercury and other contaminant levels have led some consumers to seek alternative sources of this omega-3 fatty acid. Krill oil is another marine source of EPA, derived from krill - small crustaceans that are a fundamental part of the ocean's food chain. Krill oil is noted for its unique composition, including EPA, docosahexaenoic acid (DHA), and phospholipids, which may aid in the absorption of these omega-3 fatty acids. Moreover, krill harvesting is considered to have a lower environmental impact compared to the harvesting of fish oil, making it an appealing choice for environmentally conscious consumers.

  • Application: Rising potential of eicosapentaenoic acid in functional food & beverages to provide added health benefits

    Eicosapentaenoic acid (EPA) plays a crucial role in the dietary supplements market, primarily due to its significant health benefits, including supporting heart health, reducing inflammation, and contributing to brain health. EPA supplements are widely recommended by healthcare providers to individuals lacking in omega-3 fatty acids or those needing to manage their blood lipid levels. Their formulation often comes in soft gels, capsules, or liquid forms, catering to different consumer preferences. With the rise in consumer demand for health-enhancing food products, EPA has found its place in the functional foods & beverages sector. Manufacturers are incorporating EPA into various food products, such as fortified bread, dairy products, and juices. These enriched products aim to provide added health benefits, including improved cardiovascular health and cognitive function, without altering the consumers' dietary habits significantly. In the pharmaceutical industry, EPA is acknowledged for its therapeutic properties, leading to the development of prescription drugs that target high triglyceride levels and other cardiovascular risk factors. These medications are critical for patients managing conditions such as hyperlipidemia and are often part of a comprehensive treatment plan, including diet and lifestyle changes. The pharmaceutical-grade EPA is highly purified and concentrated, ensuring maximum efficacy and safety for the patients.

Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Eicosapentaenoic Acid Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Eicosapentaenoic Acid Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Eicosapentaenoic Acid Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Eicosapentaenoic Acid Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Eicosapentaenoic Acid Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Eicosapentaenoic Acid Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Eicosapentaenoic Acid Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Eicosapentaenoic Acid Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Eicosapentaenoic Acid Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Eicosapentaenoic Acid Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

Our journey to stay ahead in the competitive market of nutritional and infant food products faced numerous challenges before we discovered the Eicosapentaenoic Acid Market Research Report by 360iResearch. This comprehensive report not only provided us with valuable insights into the rising trends in spending on nutritional and infant food products but also equipped us with actionable strategies to capitalize on these trends. With specific examples and detailed analysis, we were able to identify new market opportunities, optimize our product offerings, and improve our marketing strategies. Overall, this report has been instrumental in positively impacting our operations and driving growth for our organization. We are extremely satisfied and highly recommend this report to any company looking to gain a competitive edge in the market.
Novotech Nutraceuticals, Inc.
FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Eicosapentaenoic Acid Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Eicosapentaenoic Acid Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules

    Amneal Pharmaceuticals, Inc. and Strides Pharma Science Limited announced their strategic collaboration for the introduction of Icosapent Ethyl soft gel capsules, a VASCEPA reference product. This innovative product, available in 0.5g and 1g dosages, is an adjunctive treatment to dietary adjustments to lower triglyceride levels in adults with severe hypertriglyceridemia (≥500 mg/dL). [Published On: 2023-12-01]

  • Biomar Forms Partnership to Commercialise Omega-3 Camelina

    BioMar, a producer of salmon feed, entered into a strategic partnership with Yield10 Bioscience, a U.S.-based company, to bring to market a revolutionary genetically modified oilseed crop rich in omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), matching the levels found in traditional fish oil. This innovation presents a land-based, sustainable alternative for sourcing omega-3s, essential components in aquaculture feeds. [Published On: 2023-10-31]

  • Amarin and Neopharm Announce Exclusive Commercialization Agreement for Vazkepa (Icosapent Ethyl) in Israel

    Amarin Corporation plc and Neopharm Israel officially announced their exclusive partnership for the marketing and commercializing of VAZKEPA (icosapent ethyl) in Israel, Gaza, the West Bank, and territories under the Palestinian Authority. VAZKEPA capsules, featuring icosapent ethyl as their sole active ingredient—a highly purified form of eicosapentaenoic acid—represent the first prescription therapy of its kind. This strategic alliance leverages Neopharm's significant expertise and strong presence in cardiology to ensure VAZKEPA's accessibility to patients in need, especially those at elevated cardiovascular risk. [Published On: 2023-08-08]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Eicosapentaenoic Acid Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

As a leading player in the pharmaceutical industry, KD Pharma Group faced significant challenges in strategizing our investments to expand EPA offerings. The Eicosapentaenoic Acid Market Research Report by 360iResearch provided us with valuable insights and actionable strategies that were vital in overcoming these obstacles. By leveraging the comprehensive data and detailed analysis presented in the report, we were able to make informed decisions that not only optimized our investment plans but also enhanced our market positioning. Specific benefits included identifying key growth opportunities and understanding competitive dynamics, which have had a profound impact on our operational efficiency and market reach. We are extremely satisfied with the positive impact this report has had on our organization’s growth and operational success.
KD Pharma Group
Key Company Profiles

The report delves into recent significant developments in the Eicosapentaenoic Acid Market, highlighting leading vendors and their innovative profiles. These include Novotech Nutraceuticals, Inc., KD Pharma Group, Novasep Holding SAS, Cayman Chemical Company, Toronto Research Chemicals Inc., Sinomega Biotech Engineering Co.,Ltd., Orkla Health AS, Shandong Yuwang Pharmaceutical Co., Ltd., Pelagia AS, Golden Omega S.A., Croda International PLC, Indo Rama Engineers, Koninklijke DSM N.V., Arctic Nutrition AG, Archer Daniels Midland Company, AlgiSys BioSciences Inc., SimSon Pharma Limited, Epax Norway AS, Evonik Industries AG, Corbion N.V., BASF SE, Asterisk Laboratories (I) Pvt. Ltd., Santa Cruz Biotechnology, Inc., Omega Protein Corporation, and BIOSEARCH, SA.

Eicosapentaenoic Acid Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Eicosapentaenoic Acid Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Source
    • Algae
    • Fish
    • Krill
  • Form
    • Ethyl Esters
    • Triglycerides
  • Application
    • Dietary Supplements
    • Functional Food & Beverages
    • Pharmaceuticals

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Before utilizing the "Significance of EPA for lowering risk of rising prevalence of chronic diseases" from the Eicosapentaenoic Acid Market Research Report by 360iResearch, our organization faced difficulties navigating the complexities of the EPA market. The report's valuable insights and actionable strategies were pivotal in transforming our approach. We were able to identify key market trends, optimize our product development processes, and implement effective marketing strategies. Consequently, our market share increased significantly and we better served the needs of clients with chronic disease concerns. This report has been instrumental in positively impacting our operations, and we highly recommend 360iResearch for their comprehensive and insightful analyses.
Novasep Holding SAS
This research report offers invaluable insights into various crucial aspects of the Eicosapentaenoic Acid Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Eicosapentaenoic Acid Market, by Source
  7. Eicosapentaenoic Acid Market, by Form
  8. Eicosapentaenoic Acid Market, by Application
  9. Americas Eicosapentaenoic Acid Market
  10. Asia-Pacific Eicosapentaenoic Acid Market
  11. Europe, Middle East & Africa Eicosapentaenoic Acid Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 284]
  16. List of Companies Mentioned [Total: 25]
Understanding the Benefits of Eicosapentaenoic Acid in Promoting Better Health
July 17, 2023
BLOG
Understanding the Benefits of Eicosapentaenoic Acid in Promoting Better Health
In recent years, maintaining good health has become paramount for many individuals. This has led to a heightened awareness of different dietary components' roles in promoting better health. One such dietary component is eicosapentaenoic acid (EPA), which belongs to a family of omega-3 fatty acids. EPA is vital in promoting a healthy lifestyle due to its numerous health benefits. This blog post explores the benefits of EPA and how it contributes to better health.

EPA Helps to Regulate Inflammation:

EPA plays a vital role in regulating inflammation, a natural response in our bodies in response to tissue damage, infections, or injuries. However, when inflammation is uncontrolled, it leads to chronic diseases. EPA helps reduce inflammation by suppressing the production of inflammatory molecules called cytokines and increasing the production of anti-inflammatory cytokines. This helps to promote better health, reducing the risk of developing chronic conditions.

EPA is Great for the Brain:

Another benefit of EPA is its ability to support brain function. Research shows that EPA helps to maintain and support brain cell function, reduce the risk of developing cognitive decline, and improve mental health. EPA is also vital in promoting a healthy mood and relieving symptoms of depression, anxiety, and other mental disorders.

EPA is Good for the Heart:

EPA also plays a crucial role in promoting a healthy heart, helping to reduce the risk of heart disease by lowering blood pressure, reducing triglycerides, and preventing the formation of blood clots that can lead to heart attacks. Studies have also shown that EPA is beneficial in treating patients with existing heart conditions such as heart failure.

Helps to Maintain a Healthy Weight:

Maintaining a healthy weight is essential in promoting overall health conditions and reducing the risk of several chronic conditions. EPA is beneficial in maintaining a healthy weight as it helps to reduce inflammation, improve insulin sensitivity, and lower the risk of developing metabolic syndrome. Additionally, EPA helps to promote a feeling of fullness, thereby reducing hunger and preventing overeating.

EPA is Great for Overall Health:

EPA is great for overall health. It helps to reduce inflammation, promote brain function, maintain a healthy heart, and maintain a healthy weight. Additionally, EPA has been shown to reduce the risk of developing several chronic conditions such as cancer, type 2 diabetes, and autoimmune diseases.

Eicosapentaenoic acid (EPA) is an essential dietary component that plays a vital role in promoting better health. It helps to regulate inflammation, improve brain function, maintain a healthy heart, and maintain a healthy weight. By incorporating this important nutrient into our diet, we can reduce the risk of developing several chronic conditions, promote better health, and live longer happier lives.

Frequently Asked Questions
  1. How big is the Eicosapentaenoic Acid Market?
    Ans. The Global Eicosapentaenoic Acid Market size was estimated at USD 862.50 million in 2023 and expected to reach USD 904.94 million in 2024.
  2. What is the Eicosapentaenoic Acid Market growth?
    Ans. The Global Eicosapentaenoic Acid Market to grow USD 1,227.44 million by 2030, at a CAGR of 5.16%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.